Metastatic renal cell carcinoma: Which Medications Cause It? (1,174 Reports Across 40 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Metastatic renal cell carcinoma has been reported as an adverse event with 40 different drugs in the FDA's FAERS database, with 1,174 total reports. 496 of these reports resulted in death.The drugs most commonly associated with Metastatic renal cell carcinoma are SUNITINIB MALATE, PAZOPANIB, and AXITINIB.
1,174
Total Reports
40
Drugs Involved
496
Deaths
474
Hospitalizations
64.0 yrs
Average Patient Age
29.0% / 71.0%
Female / Male
Which Drugs Cause Metastatic renal cell carcinoma Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| SUNITINIB MALATE | 407 | 1.9% | 145 | 185 | 8 |
| PAZOPANIB | 154 | 0.7% | 78 | 61 | 8 |
| AXITINIB | 140 | 0.9% | 64 | 52 | 7 |
| EVEROLIMUS | 83 | 0.2% | 50 | 40 | 4 |
| CABOZANTINIB S-MALATE | 77 | 0.2% | 26 | 15 | 3 |
| NIVOLUMAB | 57 | 0.1% | 20 | 21 | 5 |
| TEMSIROLIMUS | 37 | 2.3% | 15 | 14 | 3 |
| SUTENT | 35 | 2.9% | 14 | 10 | 1 |
| SORAFENIB | 30 | 0.3% | 6 | 3 | 0 |
| PREDNISOLONE | 23 | 0.0% | 13 | 23 | 18 |
| METHOTREXATE | 21 | 0.0% | 1 | 14 | 5 |
| ADALIMUMAB | 17 | 0.0% | 5 | 16 | 7 |
| INLYTA | 17 | 3.4% | 10 | 4 | 0 |
| AMLODIPINE | 16 | 0.0% | 12 | 12 | 10 |
| LENVATINIB | 15 | 0.0% | 6 | 5 | 0 |
| DENOSUMAB | 13 | 0.0% | 4 | 5 | 0 |
| PREDNISONE | 13 | 0.0% | 3 | 3 | 0 |
| RITUXIMAB | 13 | 0.0% | 3 | 4 | 0 |
| VALSARTAN | 13 | 0.1% | 11 | 12 | 10 |
| BEVACIZUMAB | 12 | 0.0% | 7 | 3 | 0 |